Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 1SANOFI WINTHROP INDUSTRIE Gentilly FR
01 1Dipotassium clorazepate monohydrate
01 1France
01 1Valid
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Dipotassium clorazepate monohydrate
Certificate Number : CEP 2008-170 - Rev 02
Status : Valid
Issue Date : 2024-03-28
Type : Chemical
Substance Number : 898
20
Sanofi Winthrop Industrie Gentilly Fr, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their significant offerings is Dipotassium clorazepate monohydrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2008-170 - Rev 02
This Chemical Type CEP, issued on March 28, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 898 associated with this CEP further emphasizes
LOOKING FOR A SUPPLIER?
